
The proposal is intended to help physicians treating patients with COVID-19 for the diagnosis, treatment and prevention of venous thromboembolic disease either when leaving the hospital or treated as outpatients. This document is a synthesis of opinions of a working group from the French Society of Vascular Medicine (SFMV) composed of private practice and hospital-based physicians. This proposal is based on a limited level of evidence. This proposal is likely to evolve with the knowledge of the disease.
Pneumonia, Viral/virology, Venous Thromboembolism/virology, Pneumonia, Viral/diagnosis, MESH: Risk Assessment, MESH: Risk Factors, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Risk Factors, Ambulatory Care, MESH: COVID-19, Human health sciences, Ambulatory Care/standards, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, Pneumonia, Viral/therapy, Venous Thromboembolism, Viral / therapy, Prognosis, MESH: Betacoronavirus / pathogenicity, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, MESH: Ambulatory Care / standards, MESH: Venous Thromboembolism / prevention & control, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Cardiology and Cardiovascular Medicine, Coronavirus Infections, MESH: Pandemics, MESH: Pneumonia, Coronavirus Infections/virology, Pneumonia, Viral, Coronavirus Infections/therapy, Systèmes cardiovasculaire & respiratoire, Sciences de la santé humaine, Risk Assessment, MESH: Prognosis, Article, Betacoronavirus/pathogenicity, Betacoronavirus, MESH: Coronavirus Infections / diagnosis, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 616, Cardiovascular & respiratory systems, Humans, MESH: SARS-CoV-2, Pneumonia, Viral/epidemiology, Pandemics, Coronavirus Infections/diagnosis, SARS-CoV-2, Venous Thromboembolism/diagnosis, COVID-19, MESH: Coronavirus Infections / therapy, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control, MESH: Venous Thromboembolism / epidemiology, Coronavirus Infections/epidemiology
Pneumonia, Viral/virology, Venous Thromboembolism/virology, Pneumonia, Viral/diagnosis, MESH: Risk Assessment, MESH: Risk Factors, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Risk Factors, Ambulatory Care, MESH: COVID-19, Human health sciences, Ambulatory Care/standards, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, Pneumonia, Viral/therapy, Venous Thromboembolism, Viral / therapy, Prognosis, MESH: Betacoronavirus / pathogenicity, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, MESH: Ambulatory Care / standards, MESH: Venous Thromboembolism / prevention & control, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Cardiology and Cardiovascular Medicine, Coronavirus Infections, MESH: Pandemics, MESH: Pneumonia, Coronavirus Infections/virology, Pneumonia, Viral, Coronavirus Infections/therapy, Systèmes cardiovasculaire & respiratoire, Sciences de la santé humaine, Risk Assessment, MESH: Prognosis, Article, Betacoronavirus/pathogenicity, Betacoronavirus, MESH: Coronavirus Infections / diagnosis, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 616, Cardiovascular & respiratory systems, Humans, MESH: SARS-CoV-2, Pneumonia, Viral/epidemiology, Pandemics, Coronavirus Infections/diagnosis, SARS-CoV-2, Venous Thromboembolism/diagnosis, COVID-19, MESH: Coronavirus Infections / therapy, Venous Thromboembolism/epidemiology, Venous Thromboembolism/prevention & control, MESH: Venous Thromboembolism / epidemiology, Coronavirus Infections/epidemiology
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 20 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
